Review explores potential for improved use of anti-angiogenic agents in cancer therapy

FHS
August 9, 2024
11:39 pm

Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis.

Are dry powder inhalers the key to sustainable respiratory care? – Pharmaceutical Technology

Experts disagree on whether DPIs or low emissions pMDIs are the way forward for effective, environmentally friendly inhalers. Credit: Pixel-Shot/Shutterstock In a bid to improve

November 12, 2024

COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials

What You Should Know: – COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi. – The

April 17, 2024

Baxter to restart high-throughput IV solutions manufacturing line

Dive Brief: Baxter plans to restart its highest throughput manufacturing line for IV solutions within the next week, “barring any unanticipated developments,” the company said

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.